Yahoo Web Search

Search results

1. health.usnews.com › doctors › mina-amin-1483772Dr. Mina Amin, MD | Los Angeles, CA | Dermatologist | US News ...

   health.usnews.com › doctors › mina-amin-1483772

   • Cached

   Dr. Mina Amin is a Dermatologist in Los Angeles, CA. Find Dr. Amin's address, insurance information, hospital affiliations and more.

   • Location: Los Angeles, CA

   • Phone: 0323 783 4011

2. pubmed.ncbi.nlm.nih.gov › 30124753Quality of life with talazoparib versus physician's choice of ...

   pubmed.ncbi.nlm.nih.gov › 30124753

   Sep 1, 2018 · Quality of life with talazoparib versus physician's choice of chemotherapy in patients with advanced breast cancer and germline BRCA1/2 mutation: patient-reported outcomes from the EMBRACA phase III trial. Ann Oncol. 2018 Sep 1;29 (9):1939-1947. doi: 10.1093/annonc/mdy257.

   • Author: J. Ettl, R. G.W. Quek, Kyung-Hun Lee, H. S. Rugo, S. Hurvitz, A. Gonçalves, L. Fehrenbacher, R. Yeru...

   • Publish Year: 2018

3. www.doximity.com › pub › mina-amin-mdDr. Mina Amin, MD – Los Angeles, CA | Dermatology - Doximity

   www.doximity.com › pub › mina-amin-md

   Dr. Mina Amin, MD is a board certified dermatologist in Los Angeles, California. She is affiliated with Kaiser Permanente Los Angeles Medical Center.

   • Location: 4867 W Sunset Blvd, Los Angeles, 90027, California

   • Occupation: Physician

4. pubmed.ncbi.nlm.nih.gov › 32828825Talazoparib versus chemotherapy in patients with germline ...

   pubmed.ncbi.nlm.nih.gov › 32828825

   Results: A total of 431 patients were entered in a randomized study (287 talazoparib/144 chemotherapy) with 412 patients treated (286 talazoparib/126 chemotherapy). By 30 September 2019, 216 deaths (75.3%) occurred for talazoparib and 108 (75.0%) chemotherapy; median follow-up was 44.9 and 36.8 months, respectively.

   • Author: J.K. Litton, S.A. Hurvitz, L.A. Mina, H.S. Rugo, K.-H. Lee, A. Gonçalves, S. Diab, N. Woodward, A. G...

   • Publish Year: 2020

5. www.linkedin.com › in › minaleejungMina Jung - Provost Research Fellow for PRECOG Study - LinkedIn

   www.linkedin.com › in › minaleejung

   Provost Research Fellow for PRECOG Study. Aug 2023 - Present 1 year 2 months. Los Angeles, California, United States. Collected and monitored EEG, EOG, EKG, GSR, and 3-D spatial data from 160 ...

   • Location: Brain and Creativity Institute

6. theoncologist.onlinelibrary.wiley.com › doi › absTalazoparib in Patients with a Germline - The Oncologist

   theoncologist.onlinelibrary.wiley.com › doi › abs

   Nov 25, 2019 · In the EMBRACA phase III study (NCT01945775), talazoparib was associated with a significantly prolonged progression-free survival (PFS) compared with physician's choice of chemotherapy (PCT) in germline BRCA1/2 -mutated HER2-negative advanced breast cancer (ABC).

7. www.uclahealth.org › providers › mina-maMina W. Ma, MD - Internal Medicine - Santa Monica Primary ...

   www.uclahealth.org › providers › mina-ma

   • Cached

   5.0. | 142 ratings. Santa Monica Internal Medicine 1245 16th Street, Suite 309, Santa Monica, CA 90404. 310-319-4377. +1 more location. Request an Appointment. What insurance is accepted? About. Locations. Insurance. About. Patient Stories. Dr. Mina Ma and Dr. Leena Nathan helped me catch cancer early. Languages. English. Education.